P-242: An 8-week, double-blind, placebo-controled, multicenter, Ambulatory Blood Pressure Monitoring (ABPM) study of Teveten (Eprosartan Mesylate) 600mg and 1200mg QD in patients with essential hypertension

This was a double-blinded, placebo-controlled, parallel group, multicenter study in patients with essential hypertension (SitDBP > 95 mmHg and ≤114 mmHg). The study was composed of a 2–4 week placebo run-in period, an 8-week double-blind treatment period, and a 5–7 day post-dose follow-up period....

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	American journal of hypertension 2005-05, Vol.18 (S4), p.93A-93A
Hauptverfasser:	Punzi, Henry A., Punzi, Connie F.
Format:	Artikel
Sprache:	eng
Schlagworte:	24-Hour Ambulatory Blood Pressure Moniotring Eprosartan Mesylate Essential Hypertension
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!